omniture
GENCURIX

Latest News

Gencurix Receives Australian Government Approval for Droplex POLE Mutation Test

SEOUL, South Korea, Oct. 12, 2023 /PRNewswire/ -- Gencurix ...

2023-10-12 06:00 1659

Gencurix Obtains Approval for Companion Diagnostic of Digital PCR-based EGFR Mutation Test

SEOUL, South Korea, June 13, 2023 /PRNewswire/ -- Gencurix ...

2023-06-14 09:00 1750

Gencurix announced Korean and Japanese cancer patients' 15-year follow-up prognostic test clinical results

SEOUL, South Korea, May 9, 2023 /PRNewswire/ -- Gencurix a...

2023-05-10 08:00 2276

Gencurix wins FDA EUA for COVID-19 Test Kit

SEOUL, South Korea, June 24, 2020 /PRNewswire/ -- A Korean molecular diagnostic company, Gencurix, ...

2020-06-24 21:00 1461

Gencurix Releasing New Coronavirus Diagnostic Kit in the EU

SEOUL, South Korea, March 20, 2020 /PRNewswire/ -- A new diagnostic kit for the COVID-19, developed...

2020-03-20 16:23 2341

Gencurix's Study Explores the Difference between GenesWell BCT and Oncotype DX

SEOUL, South Korea, Aug. 23, 2019 /PRNewswire/ -- Gencurix, Inc., a molecular diagnostics company, ...

2019-08-23 08:00 2658

Gencurix Announces the First Comparison Data between GenesWell BCT and Oncotype DX

SEOUL, South Korea, Aug. 14, 2019 /PRNewswire/ -- Gencurix, Inc., a company dedicated in developmen...

2019-08-14 09:00 3291

New Publication Shows Different Result of Risk Classification between GenesWell BCT and Oncotype DX in Breast Cancer Patients 50 Years Old or Younger.

SEOUL, South Korea, Aug. 12, 2019 /PRNewswire/ -- Gencurix, Inc., a company dedicated in developmen...

2019-08-12 21:00 2448